Uma Aryal, PhD, research associate professor in the Department of Comparative Pathobiology and Purdue Proteomics Facility director. (IMAGE)

Purdue University

Uma Aryal, PhD, research associate professor in the Department of Comparative Pathobiology and Purdue Proteomics Facility director.

Caption

Greater understanding of protein aggregation relative to aging is one small step toward slowing or even reversing neurogenerative diseases. A new study in comparative pathobiology revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.

Credit

Purdue University

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.